Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Yong-Fa ChenDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of China

Wu-Bin TangDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of China

Xin-Xi PanDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of China

Chu-Rong WuDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of China

Yang CaoDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of China

Wen YangDepartment of Oncology, People’s Hospital of Nanhai District, Southern Medical University, Foshan, People’s Republic of ChinaCorrespondence[email protected]

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Yan Yuan, Jiuzhou Chen, Miao Fang, Yaru Guo, Xueqing Sun, Dehong Yu, Yilong Guo & Yong Xin. (2022) Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials. Frontiers in Oncology 12.
Crossref

Nanda Horeweg, Prachi Mittal, Patrycja L. Gradowska, Ingrid Boere, Remi A. Nout & Supriya Chopra. (2022) A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer. Critical Reviews in Oncology/Hematology 172, pages 103638.
Crossref

Yonghua Bi, Yanli Wang, Jianhao Zhang, Xiaonan Shi, Yang Wang, Miao Xu, Xinwei Han & Jianzhuang Ren. (2021) Clinical outcomes of uterine arterial chemoembolization with drug-eluting beads for advanced-stage or recurrent cervical cancer. Abdominal Radiology 46:12, pages 5715-5722.
Crossref

Shyam Ji Rawat, Rajesh Jain & Ramez Ahmed. (2020) Nimotuzumab with Concurrent Chemoradiation in the Treatment of Locally Advanced Cervical Cancer: A Single-Centre Experience. Indian Journal of Gynecologic Oncology 18:3.
Crossref

Zhonghua Xu, Hang Shu, Fan Zhang, Weiwei Luo, Yan Li, Jinjin Chu, Qihong Zhao & Yin Lv. (2020) Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma. Frontiers in Oncology 10.
Crossref

B.S Anjali Devi, Venugopal Reddy Bovilla & SubbaRao V. Madhunapantula. (2019) Current Perspectives in Human Papilloma Virus: Where We are and What We Need?. Biomedical and Pharmacology Journal 12:04, pages 1683-1700.
Crossref

Jingjing Song, Weiqian Chen, Xiaohua Zhu, Zhongwei Zhao, Minjiang Chen, Lingcong Huang, Jianfei Tu, Hongyou Zhou, Lihong Zhou & Jiansong Ji. (2019) Short‐term efficacy, safety, and cost‐effectiveness of transarterial chemoembolization with drug‐eluting beads versus synchronous radiochemotherapy for cervical cancer. International Journal of Gynecology & Obstetrics 147:1, pages 29-35.
Crossref

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date